Joseph Alukal, M.D.
NPI 1003084203 · Urology Physician · New York, NY
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1003084203
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 248400 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
365 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 226 | $107 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 62 | $149 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 22 | $132 |
| Injection Procedure to Cause Erection54235 | 17 | $104 |
| Telephone Medical Discussion With Physician, 11-20 Minutes99442 | 14 | $107 |
| Ultrasound Measurement of Bladder Capacity After Voiding51798 | 12 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Testosterone Cypionate | 28 | 15 |
| Tamsulosin Hcl | 21 | — |
| Tadalafil | 17 | — |
| Testosterone | 17 | — |
| Finasteride | 16 | — |
| Silodosin | 16 | — |
| Testosterone Enanthatebrand: Xyosted |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,972 across 24 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-02-11
- Last updated
- 2025-08-19
- Certified
- 2025-08-19
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.